Our Purpose
Healthy and safe travel - our main aim is that you can enjoy your trip in good health and that it becomes an unforgettable experience! We are at your assistance, whether with information for optimal travel preparation, vaccination recommendations, maps, tips in case of illness and much more! All information can be compiled and saved individually. The site is under construction and will be continuously expanded with additional content and updates.
Our Experts
Latest News
Get informed about the latest travel medicine news in your destination
Global: Ongoing co-circulation of influenza, RSV and SARS-CoV-2 - update
Surveillance data from ECDC’s European Respiratory Virus Surveillance Summary (ERVISS) platform and PAHO indicate continued co-circulation of influenza viruses, respiratory syncytial virus (RSV) and SARS-CoV-2 at the start of the 2025–26 Northern Hemisphere winter. In Europe, influenza A predominates with increasing hospitalizations among older adults, while RSV circulation is rising in several countries. SARS-CoV-2 activity persists at lower but stable levels. In the Americas, early-season increases in influenza and RSV activity have been reported following a severe 2025 Southern Hemisphere season.
Cruise ship “AIDAdiva”: Norovirus outbreak
CDC’s Vessel Sanitation Program reports an outbreak of acute gastroenteritis due to norovirus aboard the AIDAdiva during a journey from 10 November to 16 December 2025. The number of ill passengers exceeded the reporting threshold, prompting investigation and enhanced control measures.
Cape Verde / Europe: Travel-related shigellosis in returning travelers (update)
ECDC reports at least 193 Shigella sonnei infections in travelers returning from Cabo Verde in 2025, with most cases linked to all-inclusive resorts in Sal and Boa Vista. The outbreak strain shows resistance to trimethoprim with limited additional resistance markers.
Shigellosis outbreaks in Cape Verde have been reported in recent years, including among travelers.
Switzerland (Ticino): First autochthonous human West Nile virus case
Ticino health authorities reported the first locally acquired human West Nile virus (WNF) infection in Switzerland on 4 December 2025, in a resident who developed meningoencephalitis after mosquito exposure during summer. Previous detections of WNV in mosquitoes in Ticino suggested an established seasonal risk.
Ethiopia: Marburg virus disease outbreak is spreading
Marburg virus outbreak in Ethiopia spreads from Jinka (southern Omo region, South Ethiopia Regional State) to Hawassa, Sidama Region, located over 300 km from Jinka.
Case update:
- 12 confirmed cases including 7 confirmed deaths.
- Further 78 suspected cases are under investigation.
D.R. Congo: Ebola outbreak declared over
On 1 December 2025, the DRC Ministry of Health declared the end of the Ebola outbreak that began on 4 September 2025. The declaration followed two consecutive incubation periods (42 days) since the last confirmed patient tested negative and was discharged on 19 October.
The outbreak affected six health areas in Bulape Health Zone, Kasai Province, with 64 cases (53 confirmed, 11 probable) and 45 deaths (CFR 70.3%). This marks the DRC’s 16th Ebola outbreak.
Haiti: Rabies case in a returning US traveller
Increased cases of rabies have been reported in animals and humans in Haiti. A case of rabies has been reported in the U.S. in a traveller from Haiti.
India: Rabies case in a returning US traveller and circulation of counterfeit rabies vaccine in India
A case of rabies has been reported in the U.S. in a traveler from India.
The circulation of counterfeit ABHAYRAB human rabies vaccine has recently been reported in major cities in India, including Delhi, Mumbai, Ahmedabad, and Lucknow. The fake vaccine mimics the registered product (Abhayrab; batch KA24014) but differs in formulation, packaging, labeling, manufacturer, and expiration date, posing a serious health risk.
Ethiopia: Marburg virus disease outbreak - update
As of 24 November 2025:
- 10 cases of Marburg virus disease (MVD), including five deaths, have been confirmed in Jinka town, South Ethiopia Regional State. Five cases are currently receiving treatment (including one critically ill).
- Three additional MVD deaths are classified as probable cases (deaths before testing was available).
- More suspected MVD cases are still under investigations.
- More than 200 contacts have been identified.
- The source of the infection has not yet been identified.
No international transmission has been confirmed, but the risk remains. Jinka, though far from Ethiopia’s capital and major airports, is connected by roads to neighbouring Kenya and South Sudan and is considered as a touristic destination, especially for travelers interested in culture and anthropology. For details on MVD, see Marburg virus disease factsheet.
Before Travel
HealthyTravel Pro
HealthyTravel Pro for medical travel recommendations and consultations
- Content written by Swiss Expert Committee of Travel Medicine
- Recommended for professionals
- Updated on a weekly base
- Access to SOP
- Detailed maps
Updates of recommendations
Find out about the latest content updates on the websiteMalaria recommendation Cape Verde – update
The malaria recommendations have been updated for Cape Verde.
Schistosomiasis risk areas - update
The risk areas for schistosomiasis have been updated.
Rabies SOP vaccination pre-exposure - update
The SOP vaccination pre-exposure for rabies has been updated.
Yellow fever entry requirements - update
The yellow fever entry requirements have been updated for Jordan and Egypt.
Chikungunya Vaccination Recommendation
The Swiss Expert Committee on Travel Medicine has issued recommendations on the use of chikungunya vaccines.
Yellow Fever Country List
The 'Yellow fever country list (vaccination recommendations and countries’ entry requirements) has been updated and is available on PRO Version -> yellow fever -> documents for professionals.
Polio – updated WHO temporary recommendations
The country pages have been updated to reflect the updated WHO temporary polio recommendations.
Archive
